IR vs MR [PK / PD]

posted by jag009  – NJ, 2013-11-14 00:03 (4610 d 04:57 ago) – Posting: # 11879
Views: 6,562

Hi,

Are you referring to one IR table to one ER tablet? If so, no because that's not really the intent of a MR product. MR product has a slower rate of drug release -> 1) aim to lower the incidence of adverse events, 2) to provide a once daily blood level coverage (24 hrs).

Now I have seen submission in which BE was demonstrated between 1 MR tablet vs IR tablets given several times daily. Yes meeting the 90% CIs for AUC and Cmax. It was a 505(b)2 filing.

John

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,570 registered users;
312 visitors (0 registered, 312 guests [including 16 identified bots]).
Forum time: 06:00 CEST (Europe/Vienna)

Most scientists today are devoid of ideas, full of fear, intent on
producing some paltry result so that they can add to the flood
of inane papers that now constitutes “scientific progress”
in many areas.    Paul Feyerabend

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5